123 related articles for article (PubMed ID: 11398611)
41. Combined chemoradiation therapy for anal cancer. A report of 56 cases.
Doci R; Zucali R; Bombelli L; Montalto F; Lamonica G
Ann Surg; 1992 Feb; 215(2):150-6. PubMed ID: 1546901
[TBL] [Abstract][Full Text] [Related]
42. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
Lestrade L; De Bari B; Pommier P; Montbarbon X; Lavergne E; Ardiet JM; Carrie C
Strahlenther Onkol; 2014 Jun; 190(6):546-54. PubMed ID: 24615188
[TBL] [Abstract][Full Text] [Related]
43. Squamous cell carcinoma of the anal margin: the university of Florida experience.
Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
[TBL] [Abstract][Full Text] [Related]
44. New method of radiotherapy for anal cancer with three-dimensional tumor reconstruction based on endoanal ultrasound and ultrasound-guided afterloading therapy.
Löhnert M; Doniec JM; Kovács G; Schröder J; Dohrmann P
Dis Colon Rectum; 1998 Feb; 41(2):169-76. PubMed ID: 9556240
[TBL] [Abstract][Full Text] [Related]
45. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
[TBL] [Abstract][Full Text] [Related]
46. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
47. [The therapeutic results and early and late toxicities of the treatment of anal canal carcinoma by radiotherapy or chemoradiotherapy].
Sommer K; Brockmann WP; Wiegel T; Krüll A; Hübener KH; Birk S
Strahlenther Onkol; 1991 Aug; 167(8):445-51. PubMed ID: 1909466
[TBL] [Abstract][Full Text] [Related]
48. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
Graf R; Wust P; Hildebrandt B; Gögler H; Ullrich R; Herrmann R; Riess H; Felix R
Oncology; 2003; 65(1):14-22. PubMed ID: 12837978
[TBL] [Abstract][Full Text] [Related]
49. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy.
Weber DC; Kurtz JM; Allal AS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):675-80. PubMed ID: 11395235
[TBL] [Abstract][Full Text] [Related]
50. Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.
Bruna A; Gastelblum P; Thomas L; Chapet O; Bollet MA; Ardiet JM; Gérard JP; Peiffert D
Radiother Oncol; 2006 Apr; 79(1):75-9. PubMed ID: 16631268
[TBL] [Abstract][Full Text] [Related]
51. [Radiochemotherapy in anal canal epidermoid cancer].
Peiffert D
Ann Chir; 2000 Oct; 125(8):717-25. PubMed ID: 11105342
[TBL] [Abstract][Full Text] [Related]
52. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
[TBL] [Abstract][Full Text] [Related]
53. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma.
Hatfield P; Cooper R; Sebag-Montefiore D
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):419-24. PubMed ID: 17919842
[TBL] [Abstract][Full Text] [Related]
54. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
55. [Sphincter-preserving radiotherapy of anal carcinoma].
Thöni AF; Greiner R; Peyer T; Leicht E; Lampret T; Feuz J
Schweiz Med Wochenschr; 1992 Oct; 122(44):1689-93. PubMed ID: 1439687
[TBL] [Abstract][Full Text] [Related]
56. Treatment of anal canal carcinoma.
Shank B
Cancer; 1985 May; 55(9 Suppl):2156-62. PubMed ID: 3919927
[TBL] [Abstract][Full Text] [Related]
57. Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma.
Raffetto N; Monaco A; Banelli E
Anticancer Res; 2008; 28(2B):1335-9. PubMed ID: 18505075
[TBL] [Abstract][Full Text] [Related]
58. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
[TBL] [Abstract][Full Text] [Related]
59. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.
Chapet O; Gerard JP; Riche B; Alessio A; Mornex F; Romestaing P
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1316-24. PubMed ID: 16169674
[TBL] [Abstract][Full Text] [Related]
60. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
